123 related articles for article (PubMed ID: 11448049)
21. Compression of coated drug beads for sustained release tablet of glipizide: formulation, and dissolution.
Nguyen C; Christensen JM; Ayres JW
Pharm Dev Technol; 2014 Feb; 19(1):10-20. PubMed ID: 23259589
[TBL] [Abstract][Full Text] [Related]
22. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
Serratoni M; Newton M; Booth S; Clarke A
Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
[TBL] [Abstract][Full Text] [Related]
23. Effect of curing conditions and plasticizer level on the release of highly lipophilic drug from coated multiparticulate drug delivery system.
Hamed E; Sakr A
Pharm Dev Technol; 2003; 8(4):397-407. PubMed ID: 14601964
[TBL] [Abstract][Full Text] [Related]
24. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics.
Siepmann J; Kranz H; Bodmeier R; Peppas NA
Pharm Res; 1999 Nov; 16(11):1748-56. PubMed ID: 10571282
[TBL] [Abstract][Full Text] [Related]
25. Formulation development and optimization of bilayer tablets of aceclofenac.
Dey S; Mahanti B; Khila S; Mazumder B; Gupta SD
Expert Opin Drug Deliv; 2012 Sep; 9(9):1041-50. PubMed ID: 22788786
[TBL] [Abstract][Full Text] [Related]
26. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin.
Lee BJ; Ryu SG; Cui JH
Drug Dev Ind Pharm; 1999 Apr; 25(4):493-501. PubMed ID: 10194604
[TBL] [Abstract][Full Text] [Related]
27. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.
McConville JT; Ross AC; Florence AJ; Stevens HN
Drug Dev Ind Pharm; 2005 Jan; 31(1):79-89. PubMed ID: 15704859
[TBL] [Abstract][Full Text] [Related]
28. Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component.
Kiortsis S; Kachrimanis K; Broussali T; Malamataris S
Eur J Pharm Biopharm; 2005 Jan; 59(1):73-83. PubMed ID: 15567304
[TBL] [Abstract][Full Text] [Related]
29. Hydroxypropylmethylcellulose films for the ophthalmic delivery of diclofenac sodium.
El-Sousi S; Nácher A; Mura C; Catalán-Latorre A; Merino V; Merino-Sanjuán M; Díez-Sales O
J Pharm Pharmacol; 2013 Feb; 65(2):193-200. PubMed ID: 23278686
[TBL] [Abstract][Full Text] [Related]
30. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets.
Velasco MV; Ford JL; Rowe P; Rajabi-Siahboomi AR
J Control Release; 1999 Jan; 57(1):75-85. PubMed ID: 9863041
[TBL] [Abstract][Full Text] [Related]
31. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
[TBL] [Abstract][Full Text] [Related]
32. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose.
Ohara T; Kitamura S; Kitagawa T; Terada K
Int J Pharm; 2005 Sep; 302(1-2):95-102. PubMed ID: 16102924
[TBL] [Abstract][Full Text] [Related]
33. Drug-polymer mixed coating: a new approach for controlling drug release rates in pellets.
Nisar ur Rahman ; Yuen KH; Khan NA; Wong JW
Pharm Dev Technol; 2006 Feb; 11(1):71-7. PubMed ID: 16544910
[TBL] [Abstract][Full Text] [Related]
34. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
Maggi L; Bruni R; Conte U
Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
[TBL] [Abstract][Full Text] [Related]
35. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
Rujivipat S; Bodmeier R
Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
[TBL] [Abstract][Full Text] [Related]
36. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
Gohel MC; Sumitra G M
J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
[TBL] [Abstract][Full Text] [Related]
37. An in vitro investigation into the potential for bimodal drug release from pectin/chitosan/HPMC-coated tablets.
Macleod GS; Fell JT; Collett JH
Int J Pharm; 1999 Oct; 188(1):11-8. PubMed ID: 10528078
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of drug release in citrate buffered HPMC matrices.
Pygall SR; Kujawinski S; Timmins P; Melia CD
Int J Pharm; 2009 Mar; 370(1-2):110-20. PubMed ID: 19100822
[TBL] [Abstract][Full Text] [Related]
39. A predictive model for the release of slightly water-soluble drugs from HPMC matrices.
Fu XC; Wang GP; Wang YH; Liang WQ
Pharmazie; 2004 Aug; 59(8):624-6. PubMed ID: 15378852
[TBL] [Abstract][Full Text] [Related]
40. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
